Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease. (Q44131723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Taio Naniwa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Rei Ito

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Maiko Watanabe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yoshihito Hayami

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Shinji Maeda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Kaneshige Sasaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

15 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

32 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

S103-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and management of adult onset Still's disease

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1562-8

Adult-onset Still's disease. Clinical course and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1562-8

Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1562-8

Pathogenesis and management of adult-onset Still's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1562-8

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1562-8

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1562-8

Humanized monoclonal anti-interleukin-6 receptor antibody for treatment of intractable adult-onset Still's disease

21 January 2018

1 reference

12 December 2020

Determining virological, serological and immunological parameters of EBV infection in the development of PTLD

1 reference

12 December 2020

Tocilizumab for multirefractory adult-onset Still's disease

1 reference

12 December 2020

Preliminary criteria for classification of adult Still's disease

1 reference

12 December 2020

Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease

1 reference

12 December 2020

Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

1 reference

12 December 2020

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

1 reference

12 December 2020

Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab

1 reference

12 December 2020

A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years

1 reference

12 December 2020

10.1007/S10067-010-1562-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20842515%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference